4.7 Editorial Material

Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease

Journal

BIOMEDICINES
Volume 9, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/biomedicines9050488

Keywords

real-world evidence; chronic kidney disease; biomarkers

Ask authors/readers for more resources

The current healthcare concept promotes personalized treatment through biomarkers for chronic kidney disease patients. Prognostic markers based on real-world evidence aim to identify high-risk patients for better decision-making.
The current concept of healthcare incites a more personalized treatment of diseases. To this aim, biomarkers are needed to improve decision-making facing chronic kidney disease (CKD) patients. Prognostic markers provided by real-world (observational) evidence are proposed in this Special Issue entitled Biomarkers in Chronic Kidney Disease, with the intention to identify high-risk patients. These markers do not target measurable parameters in patients but clinical endpoints that may be in turn transformed to benefits under the effect of future interventions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available